Your browser doesn't support javascript.
loading
Case Study 6: Deconvoluting Hyperbilirubinemia-Differentiating Between Hepatotoxicity and Reversible Inhibition of UGT1A1, MRP2, or OATP1B1 in Drug Development.
Templeton, Ian; Eichenbaum, Gary; Sane, Rucha; Zhou, Jin.
Affiliation
  • Templeton I; Simcyp Division, Certara UK Ltd, Sheffield, UK. ian.templeton@certara.com.
  • Eichenbaum G; Translational Science and Safety, Office of the Chief Medical Officer, Johnson & Johnson, Raritan, NJ, USA.
  • Sane R; Department of Clinical Pharmacology, Genentech Inc., South San Francisco, CA, USA.
  • Zhou J; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA.
Methods Mol Biol ; 2342: 695-707, 2021.
Article in En | MEDLINE | ID: mdl-34272713
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bilirubin / Glucuronosyltransferase / Multidrug Resistance-Associated Proteins / Liver-Specific Organic Anion Transporter 1 / Small Molecule Libraries Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Methods Mol Biol Journal subject: BIOLOGIA MOLECULAR Year: 2021 Document type: Article Affiliation country: Reino Unido Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bilirubin / Glucuronosyltransferase / Multidrug Resistance-Associated Proteins / Liver-Specific Organic Anion Transporter 1 / Small Molecule Libraries Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Methods Mol Biol Journal subject: BIOLOGIA MOLECULAR Year: 2021 Document type: Article Affiliation country: Reino Unido Country of publication: Estados Unidos